Target intelligence / Profile preview

TBC1D3P1-DHX40P1 readthrough, transcribed pseudogene (TBC1D3P1-DHX40P1)

Target
TBC1D3P1-DHX40P1
Molecular classification
Transcribed pseudogene, non-protein coding RNA
01

Overview

TBC1D3P1-DHX40P1 readthrough, transcribed pseudogene is a non-protein coding human pseudogene locus resulting from a transcriptional readthrough between two neighboring pseudogenes: TBC1 domain family, member 3 pseudogene 1 (TBC1D3P1) and DEAH-box helicase 40 pseudogene 1 (DHX40P1). This transcript does not encode a functional protein, nor does it act as a classical receptor, enzyme, transporter, or other druggable target. It may be transcribed in certain tissues and is annotated in genome databases, but there is no evidence of biological function, disease association, or pharmacological relevance. This entry is commonly listed in reagent and genome databases because it is sometimes targeted for RNA interference experiments (to reduce non-coding transcript levels in functional studies), but it is not a canonical drug or therapy target. This makes it "incorrect" for use as a therapeutic protein, receptor, or enzyme target. TBC1D3P1-DHX40P1 is a transcribed non-coding pseudogene with no protein product nor established therapeutic relevance, appearing primarily in genome annotation and molecular biology databases for reference and research purposes.

Other names
DHX40PDHX40P1TBC1D3P1TBC1 domain family, member 3 pseudogene 1TBC1D3-DHX40 pseudogeneTBC1D3P1-DHX40P1 readthrough (non-protein coding)TBC1D3P1-DHX40P1
02

Mechanism of action

Not applicable; no therapy target mechanism

03

Biological functions

None established; pseudogenes generally do not encode proteins or have known direct biological effects
04

Disease associations

No established direct role in disease; pseudogenes are rarely associated with disease except as possible regulatory RNAs or genomic markers
05

Safety considerations

None notable
06

Interacting drugs

None
07

Biomarkers

Not currently established for patient selection or efficacy monitoring

Beyond the preview

Go deeper on TBC1D3P1-DHX40P1 readthrough, transcribed pseudogene (TBC1D3P1-DHX40P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TBC1D3P1-DHX40P1 readthrough, transcribed pseudogene (TBC1D3P1-DHX40P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call